Skip to content

Aspirin and Cancer

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Aspirin is often considered a wonder drug due to its versatile use in treating inflammation, reducing pain, and helping to prevent heart-related disease. However, there is more to it. Aspirin is actually cancer-preventive. Studies have shown that a daily low dose of aspirin, medically prescribed for more than five years, lowers the risk of cancer-related deaths by at least 30%. So, should we all start taking aspirin on a daily basis to lower our chances of getting cancer?

No, not exactly. This is because many aspects of aspirin’s cancer-preventive effects are still poorly understood. Particularly, researchers have not yet pinpointed what enables aspirin to selectively kill early-stage cancer cells and not healthy cells. This is the scope of the research currently being carried out at the Yeast Molecular Biology and Biotechnology Laboratory (headed by Prof. Rena Balzan).

Maria Azzopardi

The secret behind aspirin’s tendency to kill certain cells but not others seems to lie in the physiology of the exposed cells. Aspirin exploits the natural differences between healthy and cancerous cells to eliminate malignant cells before they can take over.

Oxygen, if transformed into ‘Reactive Oxygen Species’, is known to cause DNA mutations that can lead to cancer. Through this research, we studied mutated yeast cells which are a relevant model of early-stage cancer cells due to their low tolerance to oxygen-associated stress. We then identified genes in these mutant yeasts which are affected by aspirin.

One of aspirin’s targets is a key metabolite required for the production of energy-rich compounds vital for cell survival. We found that aspirin creates a shortage of this metabolite in mutated yeast cells, causing them to run out of energy and die.

This implies that early-stage human cancer cells may suffer a similar fate and, more importantly, partly explains how aspirin prevents tumour formation. Such knowledge may prove useful in the development of novel anti-cancer treatments.


This research was carried out as part of Project “R&I-2015-001”, financed by the Malta Council for Science & Technology through the R&I Technology Development Programme. This research is being carried out as part of Azzopardi’s Ph.D. project at the Centre for Molecular Medicine & Biobanking and the Department of Physiology & Biochemistry, University of Malta
  Author: Maria Azzopardi

Author

More to Explore

Fostering Creativity and Community: The ART Connect Project at the University of Malta Library

The Library is, in many ways, the beating heart of the University of Malta (UM). The pulse of intellectual life can be felt most profoundly amongst the quiet shelves lined with books and the many students and academics lining the Library’s work desks with their noses deep in their projects. In this sense, the Library is also symbolic of the University’s overall health and vitality, so it is important to balance serious work with serious play.

The evolution of the ART Connect Project has been a journey of dedication and transformation. Inspired by the vision of new librarians and a desire to revamp the Library’s decor, what was once a seed of an idea has now matured into a vibrant platform for artistic expression, collaboration, and community building.

The ART Connect Project aims to connect people through creativity, foster collaboration, and transform spaces, inviting artists and art enthusiasts to celebrate the power of art.

Meeting Challenges Halfway at the Malta Book Festival 2023

Malta boasts 58 registered publishing entities, hosting hundreds of authors writing books across a wide swathe of genres and formats. These numbers emerge from an NSO survey into the book industry, conducted on the basis of the year 2021. Effectively, we could say that there are ‘more authors than churches’ in Malta, with over 700 authors populating the National Book Council’s database.

This hints at a varied industry, the stakeholders of which all fall under the remit of the National Book Council, which seeks to assist, support, and represent Maltese authors and publishers, as well as related industry stakeholders such as translators and illustrators. While the Maltese context does have its own particularities, neither is it immune to the industry’s wider, global realities, a case in point being the price hike on paper caused by the war in Ukraine, which continues to be felt across the board. Maltese publishers must also bear the brunt of this unfortunate phenomenon.

The National Book Council continues to advocate for increased governmental support to aid publishers, whether in this particular challenge or others, and it also offers direct financial aid through the Malta Book Fund, which last year issued a grand total of €120,000 to various industry stakeholders, targeting projects of high cultural value which may not have a straightforward route to market success.

But while some challenges may be met halfway through financial incentives, others require a systemic — or cultural — shift in attitude from all parties involved, which takes a certain degree of workshopping to be borne out. The slow uptake of ebooks bears pondering (the NSO survey saw 146 new ebooks issued in Malta in 2021, contrasted with printed counterparts of 418 in the same year), as does the worryingly high number of authors published without adequate contracts in place.

Maximising Solar Panel Efficiency: The DustPV Project

The DustPV project, led by Prof. Ing. Joseph Micallef, aims to determine the optimal timing for cleaning solar panels using innovative sensor technology and weather data analysis. By addressing the challenges of dust accumulation on photovoltaic panels, the project seeks to enhance solar panel performance and contribute to Malta’s renewable energy goals.

No comment yet, add your voice below!


Add a Comment